BioSpace News Archive

Drug Development

Gateway for Cancer Research Announces Completion of Phase I Clinical Trial Using “Tumor Paint” in Pediatric Brain Cancer Surgery

Gateway for Cancer Research announces the completion of a Phase I clinical project led by Dr. Sarah Leary, pediatric oncologist at Seattle Children’s Hospital.

April 24, 2018

·

4 min read

Drug Development

New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsing Multiple Sclerosis To Be Presented at the 2018 American Academy of Neurology Annual Meeting

Reductions in annualized relapse rates shown in pivotal trials with ozanimod were consistent in subgroups including baseline disability, gadolinium-enhanced lesion status and prior exposure to disease-modifying therapies versus interferon beta-1a

April 24, 2018

·

7 min read

Business

Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatment

Freenome’s platform is poised to detect cancer at its earliest stages and help clinicians optimize the next generation of precision therapies.

April 24, 2018

·

3 min read

Business

ESSA Pharma Enhances R&D Capabilities with Two New Key Hires

Essa is a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer.

April 24, 2018

·

6 min read

Business

PAVmed Signs Letter of Intent with Case Western Reserve University to Commercialize Groundbreaking EsoCheck Technology

Five-minute, office-based alternative to endoscopy utilizes highly accurate DNA biomarkers to detect Barrett’s Esophagus, the precursor to a common highly lethal form of esophageal cancer

April 24, 2018

·

9 min read

Policy

ReShape Lifesciences Continues to Grow Presence in Middle East with Distribution in Bahrain

ReShape Lifesciences Inc. announced that the ReShape Balloon™ was granted registration by the National Health Regulation Authority (NHRA) in the Kingdom of Bahrain.

April 24, 2018

·

4 min read

Drug Development

CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced first patient enrollment into the pivotal U.S. REFRESH 2-AKI trial

April 24, 2018

·

5 min read

Drug Development

Checkmate Pharmaceuticals Announces Start of Phase 1b Trial of CMP-001 in Combination with Anti-PD-L1 Immunotherapy in Anti-PD-1/PD-L1 Resistant Advanced Non-Small Cell Lung Cancer

CMP-001 Clinical Studies Expand into Second Tumor Type

April 24, 2018

·

3 min read

BioMidwest

New Report Finds Procurement Leaders Prioritize Risk Management Among Most Strategic Responsibilities

A new report by A.T. Kearney and RapidRatings shows that supply chain risk management has climbed in priority among most companies, based on current geopolitical volatility.

April 24, 2018

·

3 min read

Biotech Bay

South Florida Radiation Oncology Treats First Cancer Patients Using Its New CyberKnife® M6™ System

Innovative Radiation Therapy Device Enables Cancer Center to Provide Faster, Extremely Precise Radiation Treatments

April 24, 2018

·

5 min read